Respiratory
6 drugs are in development for Healthy Participants.
- Companies
- 5
- Clinical trials
- 109
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Healthy Participants pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(2)
Phase 2(2)
| Drug | Company |
|---|---|
| ivx-a12 | Icosavax, Inc. (ICVX) |
| STAR-0310 | Astria Therapeutics, Inc. (ATXS) |
Phase 1(1)
| Drug | Company |
|---|---|
| pmn310 | ProMIS Neurosciences Inc. (PMN) |
Phase 2/Phase 3(1)
| Drug | Company |
|---|---|
| elenestinib | Blueprint Medicines Corp (BPMC) |
About this indication
Healthy Participants context
Respiratory·MeSH: Influenza, Human (D007251)
Narrower concept of MeSH descriptor Influenza
Compare drugs
Frequently asked questions
How many drugs are in development for Healthy Participants?
BioSniper tracks 6 drugs in development for Healthy Participants across 5 companies.
How many clinical trials target Healthy Participants?
There are 109 clinical trials targeting Healthy Participants tracked by BioSniper.